Picture of Neutra logo

NTRR Neutra Income Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Annual income statement for Neutra, fiscal year end - January 31st, USD millions except per share, conversion factor applied.

2020
January 31st
2021
January 31st
2022
January 31st
2023
January 31st
2024
January 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
U
USG
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue0.0060.010.0920.0680.04
Cost of Revenue
Gross Profit-0.0330.0310.0350.014
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses0.3610.4270.6640.5640.269
Operating Profit-0.355-0.417-0.572-0.496-0.229
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes-0.696-0.539-0.633-0.558-0.233
Provision for Income Taxes
Net Income After Taxes-0.696-0.539-0.633-0.561-0.233
Net Income Before Extraordinary Items
Net Income-0.696-0.539-0.633-0.561-0.233
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income-0.696-0.581-0.742-0.577-0.233
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-0.003-0.001-0-0-0